Aug. 14, 2026 — Lantheus Holdings recently announced U.S.
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
Sept. 22, 2026 — Researchers from the Keck School of Medicine of USC are developing a new “plug-and-play” platform that ...
Sept. 15, 2026 — Microstructure Imaging, Inc. (MICSI) has received FDA 510(k) clearance for MICSI-PET, a neurological ...
Sept. 10, 2026 — Siemens Healthineers Molecular Imaging has completed a $43.6 million construction and renovation ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...
Aug. 14, 2026 — Lantheus Holdings recently announced U.S. Food and Drug Administration (FDA) approval of Tauklarify ...
Aug. 18, 2026 — Cortech.AI's NeuroQuant PET has received FDA 510(k) clearance (K261916) for PET. NeuroQuant PET aids ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring ...
June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...
June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
May 29, 2026 — GE HealthCare recently announced that its MIM KineticID modeling software1 is now 510(k) pending with the ...
May 27, 2026 — A large multisite study of older people with cognitive impairment finds that Black and Hispanic people ...
May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is ...
Feb. 19, 2026 — Positrigo, a Swiss based company developing nuclear medical devices to advance functional brain imaging ...
Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...
Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...
Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...
Dec.16, 2025 — Three international nuclear medicine organizations — the SNMMI Clinical Trials Network (SNMMI-CTN), the ...
Nov. 18, 2025 — Siemens Healthineers positron emission tomography (PET) radiopharmaceutical companies PETNET Solutions ...
September 23, 2026 